Friday, February 12, 2016

Oracle purchases Ndevr environmental IP and business intelligence

February 28, 2011 by · Leave a Comment 






“Oracle has acquired the IP and business intelligence of certain assets of Melbourne-based partner, Ndevr.  The financial details of the deal haven’t been disclosed.  The acquisition will add environmental reporting and business intelligence capabilities to Oracle’s ERP solutions.”

Abbott Wins Reversal of J&J’s $1.67 Billion Patent Victory

February 28, 2011 by · Leave a Comment 






“Abbott Laboratories, maker of the arthritis drug Humira, succeeded in a bid to overturn a $1.67 billion patent-infringement verdict won by Johnson & Johnson.” “The 2009 verdict, the largest patent-related damages award in U.S. history, was reversed today by the U.S. Court of Appeals for the Federal Circuit in Washington, according to the court’s website. […]

CWRU tech transfer VP Coticchia resigns, plans to start new company

February 28, 2011 by · Leave a Comment 






“Case Western Reserve University’s top technology transfer official is resigning from the university to start a new technology transfer and venture development consulting firm. Mark Coticchia’s resignation is effective April 1. He joined Case in 2001.”

Farmington Hills’ CSquared Innovations wins Clean Energy Prize

February 24, 2011 by · Leave a Comment 






“Many of the most promising start-ups spinning out of the Great Lakes State have two things in common. They’re based in Ann Arbor and come from the University of Michigan. CSquared Innovations has one of those traits — sort of.” “The Farmington Hills-based start-up first discovered its lithium-ion battery technology at the University of Michiagan-Dearborn […]

Intel announces Thunderbolt Technology

February 24, 2011 by · Leave a Comment 






“Intel Corporation today announced the availability of Thunderbolt technology, a new high-speed PC connection that brings together high-speed data transfer and high-definition (HD) display onto a single cable.”

PDL will pay Gaithersburg-based MedImmune $92.5M in patent settlement

February 22, 2011 by · Leave a Comment 






“NEW YORK — PDL BioPharma Inc. said Wednesday it will pay a total of $92.5 million to settle a patent dispute with AstraZeneca PLC’s MedImmune unit, and added that MedImmune will not pay any further royalties on sales of its virus treatment Synagis. PDL said it has paid MedImmune $65 million.”

Juxtopia Awarded National Science Foundation Grant

February 22, 2011 by · Leave a Comment 






“BALTIMORE, MD — Juxtopia LLC, an innovative technology company with a focus on building products to improve human performance, announced today that it has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) supplement grant. The grant was effective.”

Jackson Walker, LLP Elects Ten New Partners

February 20, 2011 by · Leave a Comment 






“NewswireToday – /newswire/ – Dallas, TX, United States, 02/15/2011 – Jackson Walker, LLP announces the election of ten attorneys to the firm’s partnership.” “From the Dallas office, Virginia Alverson, Heather Forrest, Andrew Graham, Amy Roberts, and Debbie Robinowitz were named partners. From the Fort Worth office, Amanda Bush and Danielle Needham were named partners. From […]

David Henry Joins Dykema in Dallas

February 20, 2011 by · Leave a Comment 






“Dykema, a leading national law firm, today announced the addition of David G. Henry to its Intellectual Property (IP) Department as a member in the firm’s Dallas office. Prior to joining Dykema, Henry was a partner with Patton Boggs LLP, where he headed the Texas IP practice. He will also spend time in Dykema’s Washington, […]

Simpson Thacher, Latham & Watkins advised AOL, Huffington Post on $315 mln deal

February 20, 2011 by · Leave a Comment 






“Digital media giant AOL and popular political blog site The Huffington Post had hired Simpson, Thacher & Barlett and Latham & Watkins respectively to advise them on the recently announced $315 million acquisition deal.”

Ion Geophysical wins patent suit, to get $10.7 mln

February 20, 2011 by · Leave a Comment 






“Feb 17 (Reuters) – Seismic software provider Ion Geophysical Corp said it won a patent suit against Sercel Inc, a seismic equipment provider, and was awarded $10.7 million plus interest in damages.” “A federal court in Texas imposed a permanent injunction against Sercel over a patent covering multicomponent (full-wave) seismic sensor technology, Ion said in […]

GIS Appoints Marek Wernik as President and CEO

February 20, 2011 by · Leave a Comment 






“Global Intellectual Strategies, Inc., today announce the appointment of Marek Wernik as the company’s new president and chief executive officer. Mr. Wernik takes over the day-to-day operations and business strategy responsibilities from Pierrette Breton, founder of Global Intellectual Strategies (GIS). Pierrette Breton will transition out of the day-to-day role in the company to work as […]

Teresa Stanek Rea Named New Deputy Director of the USPTO

February 20, 2011 by · Leave a Comment 






“In an e-mail circulated within the United States Patent and Trademark Office earlier today USPTO Director David Kappos announced that Teresa Stanek Rea has been appointed to be the new Deputy Director of the USPTO. Rea will start in her new role on March 1, 2011. According to a press release issued by the USPTO: […]

Two More IP Partners Leave Howrey

February 20, 2011 by · Leave a Comment 






“The recent string of partner defections from Howrey has hit one of the firm’s Southern California offices with the announcement on Tuesday that intellectual property partners William Rooklidge and Frank Coté would be joining Jones Day’s Irvine, Calif., office.” “Rooklidge, who was co-chairman of Howrey’s worldwide intellectual property practice, was widely expected to leave following […]

Sanofi in $20bn Genzyme deal

February 20, 2011 by · Leave a Comment 






‘The French pharmaceutical group Sanofi-aventis has agreed to buy Genzyme for $20.1bn (£12.5bn), in one of the biggest global M&A deals since the financial crisis.” “The agreement between the two parties brings to a close Sanofi’s six-month public pursuit of the American biotechnology company, which specialises in rare diseases.” “Sanofi has agreed to pay $74-a-share […]

Next Page »